Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Alaunos Therapeutics(TCRT) the EBIT is -952 K (+8.37%);the EPS is -0.391 (+37.56%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B8.37%
----
----
EPS
-0.391537.56%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf